Sandrine Lemoine1, Marie Courbebaisse2
1Service de néphrologie et d'exploration fonctionnelle rénale, centre de référence maladies rénales rares Néphrogones, Hospices civils de Lyon, université de Lyon, France.
Small interfering RNAs (siRNAs) offer targeted mRNA degradation for therapeutic benefits. Rapid advancements have led to approved treatments and ongoing clinical trials for various diseases, including kidney and cardiovascular conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: